Skip to main content
. 2007 Dec 28;1(4):395–405. doi: 10.1016/j.molonc.2007.12.003

Table 1.

NRAS mutations in melanoma tumours

Primary melanomas N mut/total N (%) Metastases N mut/total N (%) Material Sub‐dissection Detection method Reference
2/36 (6) P No D,E Shukla et al., 1989
1/19 (5) 1/16 (6) P No D,E Albino et al., 1989
5/10 (50) 21/40 (53) F No D,E van't Veer et al., 1989
4/31 (13) 2/8 (35) P No D,E,I Carr and Mackie, 1994
18/71 (25) 6/17 (35) P No D,E,I Ball et al., 1994
6/30 (20)a P No D,E,I Platz et al., 1994
15/35 (43)b
1/18 (5.5) 3/13(23) F No D,H,I Jafari et al., 1995
27/175 (15) 19/36 (16) P No D,F,I van Elsas et al., 1996
11/46 (24)c P No D,F,I Jiveskog et al., 1998
2/28 (7)d
22/69 (32) 14/33 (42) F Yes D,F Demunter et al., 2001a
21/74 (28) 33/88 (38) P Yes D,F,I Omholt et al., 2002
26/82 (32) F No D,K Sivertsson et al., 2002
20/21 (95)e P Yes D,I Eskandarpour et al., 2003
1/10 (10)f
7/24 (29) P Yes D,H,I Pollock et al., 2003
1/27 (4) P No D,G,I Cruz et al., 2003
13/35 (37) P No D,F,I Kumar et al., 2003a
3/38 (8) P No D,F,I Kumar et al., 2003b
5/25 (20) 12/60 (20) F No D,H Alsina et al., 2003
3/77 (4) F No D,I Gorden et al., 2003
4/28 (14) P Yes D,I Dong et al., 2003
2/17 (12) P No D,F,I Tsao et al., 2004
2/15 (13) 4/22 (18) F No D,F,I Reifenberger et al., 2004
20/114 (17.5) 21/86 (24) P Yes D,I Houben et al., 2004
3/12 (25) P No D,F,I Saldanha et al., 2004
14/51 (27)g 4/18 (22) P Yes D,F,I Akslen et al., 2005
4/36 (11) 17/79 (22) F No D,H Goydos et al., 2005
4/27 (15)h P No D,I Curtin et al., 2006
8/37 (22)i
10/60 (17) P Yes D,I Goel et al., 2006
86/294 (29)j F No D,K Edlundh‐Rose et al., 2006
19/97 (20) F No D,G,I Ugurel et al., 2007
Total 223/1075 (21) 315/1210 (26)

Materials: F=fresh frozen tissues, P=formalin fixed tissues, paraffin embedded. Manual or laser capture sub‐dissection: yes/no. Detection Method: D=PCR, RT‐PCR; E=allele specific oligonucleotide hybridization; F=single strand conformation polymorphism (SSCP) analyses; denaturing gradient gelelectrophoresis (DGGE) analyses; G=HPLC/capillary techniques; H=RFLP dependent or allele specific amplification; I=nucleotide sequence analysis; K=pyrosequencing.

a

From sporadic melanoma.

b

From hereditary melanoma.

c

Melanomas in sun exposed sites.

d

Melanomas in mucous membranes.

e

Hereditary melanomas with germline CDKN2A mutations.

f

Sporadic melanomas.

g

NM only.

h

Chronically sun exposed sites, mainly LMM.

i

Intermittently sun exposed sites, mainly SSM.

j

Including 39 primary tumours.